Schulak J A, Nghiem D D, Ercolani L, Corry R J
Am J Surg. 1984 Feb;147(2):269-72. doi: 10.1016/0002-9610(84)90105-3.
To determine the feasibility of third kidney transplantation, the experience at the University of Iowa was evaluated. The success of 14 such transplantations was dependent on the outcome of both of the previous graft operations. Three successful third transplantations with graft survival of 6 years, 3 years, and 1 year have occurred in recipients with more than 1 year survival of a previous kidney. Conversely, graft loss due to rejection developed in all patients who experienced graft survival of less than 1 year for both antecedent grafts. Moreover, HLA-A and -B matching and level of presensitization were not predictive of success in this series. These data suggest that third kidney transplantation using conventional immunosuppression may not be appropriate in the subgroup of patients who have clearly lost their first two grafts to early rejection.
为确定第三次肾脏移植的可行性,对艾奥瓦大学的经验进行了评估。这14例此类移植的成功取决于前两次移植手术的结果。在先前肾脏存活超过1年的受者中,发生了3例成功的第三次移植,移植肾存活时间分别为6年、3年和1年。相反,在前两次移植肾存活时间均少于1年的所有患者中,均因排斥反应导致移植肾丢失。此外,在该系列中,HLA - A和 - B配型以及致敏水平并不能预测移植成功。这些数据表明,对于因早期排斥反应明显失去前两个移植肾的患者亚组,使用传统免疫抑制进行第三次肾脏移植可能并不合适。